Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Fig. 3

Cumulative incidence function (CIF) for loco-regional recurrences as the first site of relapse for patients treated with definitive radiochemotherapy (RCTx 1) or neoadjuvant radiochemotherapy followed by surgery (trimodal 2). Concurrent risks were distant metastases or secondary cancers. The background areas of the same colour as the CIF represent the pointwise 95% confidence. Also moderate, the incidences of loco-regional recurrences were significantly higher after definitive radiochemotherapy in comparison to trimodality (p = 0.0012 Gray’s test)

Back to article page